MENU
IMMP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immutep (IMMP) Ownership - Who owns Immutep?

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
264 George Street
Phone
+61 283157003
Employees
51
Web
https://www.immutep.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
492.22M
P/E Ratio
-0.31
Total Cash
68.87M
Projected Growth
N/A
Total Debt
1.05M
Revenue
14.56M
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
1.39 USD as % of share price
Who owns Immutep? IMMP symbol Ownership - Tickeron.com